Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145944

Pw145944 View Pathway
drug action

Avibactam Drug Metabolism Action Pathway

Homo sapiens

PW252853

Pw252853 View Pathway
metabolic

Avermectin B2a biosynthesis

Streptomyces avermitilis
Avermectin B2a biosynthesis involves several enzymatic reactions that convert simple precursors into a potent anthelmintic compound crucial for both bacterial metabolism and human medicine. The pathway starts with type I polyketide synthase (PKS) AVES 1, which elongates the carbon chain from 2-methylbutyryl-CoA, malonyl-CoA, and methylmalonyl-CoA to produce 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone. This intermediate is then hydroxylated by cytochrome P450 hydroxylase to form 5-oxoavermectin "2a" aglycone, which is further reduced by C-5 ketoreductase to yield avermectin B2a aglycone. The addition of sugar moieties by glycosyltransferase enzymes, specifically dTDP-L-oleandrose transferase, completes the biosynthesis, resulting in avermectin B2a. This pathway is vital for as it provides a mechanism for producing bioactive compounds that can inhibit competing microorganisms. Additionally, avermectin B2a can be used in treating parasitic infections.

PW251844

Pw251844 View Pathway
metabolic

Avermectin A1a biosynthesis

Streptomyces avermitilis
Avermectin A1a biosynthesis involves multiple enzymatic steps that convert simple precursors like 2-methylbutyryl-CoA, malonyl-CoA, and methylmalonyl-CoA into the final potent anthelmintic compound. The process begins with chain elongation by type I polyketide synthase (PKS) AVES 1, forming 6,8a-seco-6,8a-deoxy-5-oxoavermectin "1a" aglycone. This intermediate is hydroxylated by cytochrome P450 hydroxylase, reduced by C-5 ketoreductase to avermectin B1a aglycone, and methylated by C5-O-methyltransferase to form avermectin A1a aglycone. Finally, glycosyltransferases add sugar moieties, resulting in avermectin A1a. This biosynthetic pathway yields aAvermectin A1a which has significant agricultural and medical applications as well as protecting bacteria from other competitive microorganisms.

PW176242

Pw176242 View Pathway
metabolic

Avatrombopag Predicted Metabolism Pathway

Homo sapiens
Metabolites of Avatrombopag are predicted with biotransformer.

PW146483

Pw146483 View Pathway
drug action

Avatrombopag Drug Metabolism Action Pathway

Homo sapiens

PW146909

Pw146909 View Pathway
drug action

Avapritinib Drug Metabolism Action Pathway

Homo sapiens

PW132561

Pw132561 View Pathway
metabolic

Avapritinib Drug Metabolism

Homo sapiens
Avapritinib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Avapritinib passes through the liver and is then excreted from the body mainly through the kidney.

PW145691

Pw145691 View Pathway
drug action

Avanafil Drug Metabolism Action Pathway

Homo sapiens

PW175975

Pw175975 View Pathway
metabolic

Avacopan Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Avacopan are predicted with biotransformer.

PW146903

Pw146903 View Pathway
drug action

Avacopan Drug Metabolism Action Pathway

Homo sapiens